We are live on ! Find out more
LAB icon

Standard BioTools
LAB

134 hedge funds and large institutions have $472M invested in Standard BioTools in 2020 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 27 increasing their positions, 54 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

122% more call options, than puts

Call options by funds: $9.54M | Put options by funds: $4.3M

121% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 19

89% more capital invested

Capital invested by funds: $249M → $472M (+$223M)

20% more funds holding

Funds holding: 112 → 134 (+22)

4.79% more ownership

Funds ownership: 87.97% → 92.76% (+4.8%)

50% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 54

Holders
134
Holders Change
+22
Holders Change %
+19.64%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.08%
New
42
Increased
27
Reduced
54
Closed
19
Calls
$9.54M
Puts
$4.3M
Net Calls
+$5.24M
Net Calls Change
+$4.89M

Top Buyers

Rank Fund Capital Flow
1
AI
Atom Investors
Texas
+$22.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$20.8M
3
Invesco
Invesco
Georgia
+$14.6M
4
Millennium Management
Millennium Management
New York
+$8.37M
5
ACM
Asymmetry Capital Management
California
+$6.75M

Top Sellers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
-$9.23M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$9.14M
3
Renaissance Technologies
Renaissance Technologies
New York
-$7.99M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.53M
5
PHS
PFM Health Sciences
California
-$5.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Alexandria Capital
Virginia
$4.99M – – –
Voloridge Investment Management
27
Voloridge Investment Management
Florida
$4.91M +$4.56M +660,110 New
UBS Group
28
UBS Group
Switzerland
$4.21M -$2.67M -386,543 -41%
Alyeska Investment Group
29
Alyeska Investment Group
Illinois
$4.18M +$1.52M +220,895 +65%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$3.91M +$625K +90,572 +21%
Arrowstreet Capital
31
Arrowstreet Capital
Massachusetts
$3.19M -$2.5M -361,490 -46%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$3.11M -$530K -76,714 -15%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$2.87M -$6.53M -945,502 -71%
Norges Bank
34
Norges Bank
Norway
$2.5M -$2.14M -310,606 -48%
PCM
35
Perkins Capital Management
Minnesota
$2.47M +$2.29M +332,425 New
CC
36
Clearline Capital
New York
$2.28M +$2.12M +306,829 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$2.19M -$5.91M -856,072 -74%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.15M +$1.15M +166,717 +137%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$2.13M -$4.61M -667,874 -70%
CS
40
Candriam SCA
Luxembourg
$2.12M +$1.97M +285,000 New
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$1.88M -$1.15M -166,620 -40%
RCMC
42
RK Capital Management (Colorado)
Colorado
$1.86M +$1.73M +250,900 New
Citadel Advisors
43
Citadel Advisors
Florida
$1.73M +$1.61M +232,906 New
PP
44
PDT Partners
New York
$1.61M +$1.5M +217,066 New
SSA
45
Schonfeld Strategic Advisors
New York
$1.56M +$1.45M +210,600 New
HSA
46
Hussman Strategic Advisors
Maryland
$1.52M +$1.41M +204,000 New
ECM
47
ExodusPoint Capital Management
New York
$1.37M +$1.27M +183,863 New
Charles Schwab
48
Charles Schwab
California
$1.24M -$39.3K -5,693 -3%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.22M +$54.5K +7,896 +5%
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.21M -$862K -124,874 -43%
1
2
3 4 5

LAB Hedge Fund Activity: Q3 2020 in Review

134 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2020, worth a combined $472M — up 89% from $249M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new LAB positions and 19 closed out — a net gain of 23 holders — while 27 added to existing stakes and 54 trimmed.

The largest buyer was Atom Investors, opening a new position worth an estimated $22.1M. The largest seller was Neuberger Berman Group, cutting an estimated $9.23M.

  • 134 institutional investors held Standard BioTools (LAB) as of Q3 2020, up from 112 in Q2 2020.
  • Funds reported $472M of Standard BioTools stock for Q3 2020, up 89% quarter-over-quarter.
  • 42 funds opened new Standard BioTools positions in Q3 2020 and 19 closed out, a net change of +23 holders.
  • The largest Standard BioTools buyer in Q3 2020 was Atom Investors, an estimated $22.1M added.
  • The largest Standard BioTools seller in Q3 2020 was Neuberger Berman Group, an estimated $9.23M sold.

Based on aggregated 13F filings for Q3 2020.